181 Spinal deformities (SD) in young CF patients: two years experience of screening and follow up

181 Spinal deformities (SD) in young CF patients: two years experience of screening and follow up

Posters 9. Physiotherapy 181 Spinal deformities (SD) in young CF patients: two years experience of screening and follow up G. Mamprin1 , F. Lucca2 ,...

62KB Sizes 0 Downloads 18 Views

Posters

9. Physiotherapy

181 Spinal deformities (SD) in young CF patients: two years experience of screening and follow up G. Mamprin1 , F. Lucca2 , S. Gaiotto3 , M. Barbisan1 , M.G. Toffolo1 , L. Da Dalt4 , M. Ros1 . 1 Ca’ Foncello Hospital, Cystic Fibrosis Center, Pediatric Department, Treviso, Italy; 2 Padova University, Pediatric Department, Padova, Italy; 3 Ca’ Foncello Hospital, Physical Therapy Department, Treviso, Italy; 4 Ca’ Foncello Hospital, Pediatric Department, Treviso, Italy Background: Increased survival in CF patients (pts) requires assessment of extrapulmonary morbidities, as SD. Scoliosis (S) is more frequent in CF than in general population; it causes functional spinal disorders and restrictive pulmonary disease and may be influenced by CF musculoskeletal involvement. Aims: To describe: • SD distribution in a group of CF pts • SD and clinical status relationship • 2 years follow up in a subgroup Methods: Respiratory therapist measured the angle of trunk rotation (ATR) with scoliometer in the Adams forward bending test position in CF pts, 6−19 years old (yrs). Results: 58 pts (M 46.55%, aged 12.45±3.61 yrs, median %ile for weight 39.22 and for height 49.12, mean FEV1 91.79±16.94%pred ) were enrolled. No difference at baseline existed between males and females. Pts were divided in: (1) Negative group (N): ATR 0−4º (n = 48); (2) Positive group (P): ATR 5º (n = 10). Pts in P were older (p = 0.001); N had greater FVC%pred (p = 0.008). 6 thoracic (60%), 3 lumbar (30%) and 1 thoracolumbar (10%) curves (70% with right convexity) were found. Specialized physician prescribed 10 spine x-ray diagnosing S (>10º Cobb) in 3 pts (5.17%) with indication of brace. ATR correlated with height %ile (r = 0.7; p = 0.02) in P; no relationship with lung function was found. 36 pts were reassessed 2 years after the 1st evaluation. ATR was the same in 52.78% of pts, while it increased in 25%. Changes in ATR didn’t correlate with respiratory and nutritional status. Conclusion: Our data justify SD early screening and at least yearly reassessment because of their possible progression and lack of correlation with clinical data. A study to assess S and back pain prevalence in adult CF pts is ongoing.

S93

183 Mycobacterium abscessus: stand alone hospital admission for agressive physiotherapy and nutritional review can extend periods between toxic IV antibiotic treatments J. Tame1 , A. Turnbull1 , J. Forton1,2 . 1 Noah’s Ark Children’s Hospital for Wales, University Hospital of Wales, Department of Paediatric Respiratory Medicine, Cardiff, United Kingdom; 2 Cardiff University, Department of Child Health, Cardiff, United Kingdom Objectives: Treatment for chronic M. abscessus infection comprises maintenance therapy with oral and nebulised antibiotics, coupled with periodic exacerbation therapy with IV antibiotics. Typically lung function and weight gain improves with treatment of exacerbations, and there is interval loss in lung function and weight while on maintenance therapy. We report a case of an adolescent with chronic symptomatic M. abscessus infection, who needs hospital admission 2−3 monthly to sustain lung function. Severe nausea and vomiting has complicated IV treatment and so some admissions are limited to aggressive airway clearance and nutritional review without IV antibiotics. We sought to compare outcomes between those admissions with and without IV antibiotic therapy. Methods: We retrospectively analysed weight and lung function profiles over 15 months and across 6 hospital admissions. Results: For admissions involving IV antibiotic therapy, we identified a paradoxical pattern of improvement in lung function with loss of weight, as a consequence of nausea and vomiting during treatment. Catch up in weight was seen between hospital admssions. Admissions for MDT support without IV antibiotics showed equivalent benefits in lung function, but also demonstrated good weight gain. Conclusion: In patients who require frequent admissions for chest exacerbations, antibiotic tolerance and drug toxicity represent barriers to treatment which need careful consideration. Introducing short admissions for MDT support without IV antibiotic therapy can produce equivalent improvements in lung function and weight gain and can be used to extend periods between toxic IV antibiotic treatments.